{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:07:03Z","timestamp":1774494423119,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,17]]},"DOI":"10.7759\/cureus.54350","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T11:48:21Z","timestamp":1708170501000},"source":"Crossref","is-referenced-by-count":1,"title":["Human Herpesvirus-8 (HHV-8)-Positive Human Immunodeficiency Virus (HIV)-Negative Multicentric Castleman Disease With a Fulminant Course"],"prefix":"10.7759","author":[{"given":"Maria Teresa","family":"Brito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Filipa","family":"Amador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Mo\u00e7o Coutinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge S","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.03.009","article-title":"Human herpesvirus type 8-positive multicentric Castleman disease","volume":"16 Suppl","author":"Melikyan AL","year":"2016","unstructured":"Melikyan AL, Egorova EK, Julhakyan HL, Kovrigina AL, Savchenko VG. Human herpesvirus type 8-positive multicentric Castleman disease. Clin Lymphoma Myeloma Leuk. 2016, 16 Suppl:S159-65. 10.1016\/j.clml.2016.03.009","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-013-0248-1","article-title":"Bone marrow involvement in multicentric Castleman disease in a HIV negative patient","volume":"30","author":"Agrawal P","year":"2014","unstructured":"Agrawal P, Naseem S, Varma N, Sharma P, Malhotra P, Varma S. Bone marrow involvement in multicentric Castleman disease in a HIV negative patient. Indian J Hematol Blood Transfus. 2014, 30:60-3. 10.1007\/s12288-013-0248-1","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2016.01.002","article-title":"A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination","volume":"22","author":"Kantarci FE","year":"2016","unstructured":"Kantarci FE, Eren R, G\u00fcndo\u011fan C, Huq GE, Do\u011fu MH, Suyan\u0131 E. A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination. J Infect Chemother. 2016, 22:483-5. 10.1016\/j.jiac.2016.01.002","journal-title":"J Infect Chemother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis1009","article-title":"Human herpesvirus 8-related Castleman disease in the absence of HIV infection","volume":"56","author":"Dossier A","year":"2013","unstructured":"Dossier A, Meignin V, Fieschi C, Boutboul D, Oksenhendler E, Galicier L. Human herpesvirus 8-related Castleman disease in the absence of HIV infection. Clin Infect Dis. 2013, 56:833-42. 10.1093\/cid\/cis1009","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2018.1789","article-title":"Human immunodeficiency virus-negative multicentric Castleman's disease coexistent with Kaposi's sarcoma on (18)F-FDG PET\/CT: a case report","volume":"10","author":"Hwang JP","year":"2019","unstructured":"Hwang JP, Kim J, Park JM. Human immunodeficiency virus-negative multicentric Castleman's disease coexistent with Kaposi's sarcoma on (18)F-FDG PET\/CT: a case report. Mol Clin Oncol. 2019, 10:318-20. 10.3892\/mco.2018.1789","journal-title":"Mol Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-018-2647-z","article-title":"Analysis of clinical characteristics and prognosis factors of 71 cases with HIV-negative Castleman's disease: hypoproteinemia is an unfavorable prognostic factor which should be treated appropriately","volume":"144","author":"Lan X","year":"2018","unstructured":"Lan X, Li Z, Zhang M. Analysis of clinical characteristics and prognosis factors of 71 cases with HIV-negative Castleman's disease: hypoproteinemia is an unfavorable prognostic factor which should be treated appropriately. J Cancer Res Clin Oncol. 2018, 144:1265-77. 10.1007\/s00432-018-2647-z","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10500","article-title":"Multicentric Castleman's disease treated with antivirals and immunosuppressants","volume":"71","author":"Senanayake S","year":"2003","unstructured":"Senanayake S, Kelly J, Lloyd A, Waliuzzaman Z, Goldstein D, Rawlinson W. Multicentric Castleman's disease treated with antivirals and immunosuppressants. J Med Virol. 2003, 71:399-403. 10.1002\/jmv.10500","journal-title":"J Med Virol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-333633","article-title":"Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease","volume":"118","author":"Hoffmann C","year":"2011","unstructured":"Hoffmann C, Schmid H, M\u00fcller M, et al.. Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease. Blood. 2011, 118:3499-503. 10.1182\/blood-2011-02-333633","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12472","article-title":"Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient","volume":"42","author":"Murphy C","year":"2017","unstructured":"Murphy C, Hawkes E, Chionh F, Chong G. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient. J Clin Pharm Ther. 2017, 42:111-4. 10.1111\/jcpt.12472","journal-title":"J Clin Pharm Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.53.69","article-title":"Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute","volume":"53","author":"Kawabata H","year":"2013","unstructured":"Kawabata H, Kadowaki N, Nishikori M, et al.. Clinical features and treatment of multicentric castleman's disease : a retrospective study of 21 Japanese patients at a single institute. J Clin Exp Hematop. 2013, 53:69-77. 10.3960\/jslrt.53.69","journal-title":"J Clin Exp Hematop"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/225649-human-herpesvirus-8-hhv-8-positive-human-immunodeficiency-virus-hiv-negative-multicentric-castleman-disease-with-a-fulminant-course","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T11:48:23Z","timestamp":1708170503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/225649-human-herpesvirus-8-hhv-8-positive-human-immunodeficiency-virus-hiv-negative-multicentric-castleman-disease-with-a-fulminant-course"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,17]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.54350","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,17]]}}}